Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
- DOI
- 10.1136/bmjopen-2021-053201
- Published
- 2021 Nov 23
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2021-053201,
title = {Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.},
author = {Beaumont A and Durand C and Ledrans M and Schwoebel V and Noel H and Le Strat Y and Diulius D and Colombain L and Médus M and Gueudet P and Mouly D and Aumaître H},
year = {2021},
journal = {BMJ open},
doi = {10.1136/bmjopen-2021-053201},
url = {https://doi.org/10.1136/bmjopen-2021-053201}
}RIS
TY - JOUR TI - Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study. AU - Beaumont A AU - Durand C AU - Ledrans M AU - Schwoebel V AU - Noel H AU - Le Strat Y AU - Diulius D AU - Colombain L AU - Médus M AU - Gueudet P AU - Mouly D AU - Aumaître H PY - 2021 JO - BMJ open DO - 10.1136/bmjopen-2021-053201 UR - https://doi.org/10.1136/bmjopen-2021-053201 ER -
APA
A, B., C, D., M, L., V, S., H, N., Y, L. S., D, D., L, C., M, M., P, G., D, M., & H, A. (2021). Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.. BMJ open. https://doi.org/10.1136/bmjopen-2021-053201
Source records
- pubmed · retrieved 2026-09-27T15:52:24.379Z